The Journal of Organic Chemistry
Article
1.37 (m, 1H), 1.32−1.27 (m, 1H), 0.66 (s, 9H); 13C NMR (101 MHz,
CDCl3) δ 165.1 (d, J = 4.6 Hz), 161.9 (q, J = 50.0 Hz), 144.3 (d, J =
21.1 Hz), 144.0 (d, J = 6.4 Hz), 143.6, 143.0 (d, J = 2.3 Hz), 142.8 (d,
J = 12.1 Hz), 142.3 (d, J = 2.0 Hz), 138.4 (d, J = 2.5 Hz), 135.0, 133.8
(d, J = 7.7 Hz), 133.4 (d, J = 8.1 Hz), 133.1 (d, J = 7.3 Hz), 132.6 (d,
J = 8.6 Hz), 132.4 (d, J = 10.2 Hz), 131.9, 131.8 (d, J = 15.9 Hz), 130.1
(d, J = 67.8 Hz), 129.1 (qq, J = 31.6, 2.8 Hz), 127.6 (d, J = 12.6 Hz),
123.4 (q, J = 272.6 Hz), 117.7 (brs), 115.3, 114.8, 89.9 (d, J = 9.2 Hz),
82.5 (d, J = 16.1 Hz), 73.9, 70.0, 69.7, 69.2, 35.9 (d, J = 5.9 Hz), 34.8,
33.5, 31.7 (d, J = 13.6 Hz), 28.7 (d, J = 8.3 Hz), 27. 8, 25.9, 25.4,
24.97, 23.0, 20.8, 20.6; 31P NMR (162 MHz, CDCl3) δ 2.7; 19F NMR
(376 MHz, CDCl3) δ −62.8.
General Procedure for the Hydrogenation of Oxy-Cope Products.
Into a glass vial equipped with a magnetic stir bar were inserted the
substrate and 2 mol % of the Ir catalyst. The mixture was dissolved in
dry CH2Cl2 (c = 0.3−0.6 M). The vial was placed into the hydrogena-
tion autoclave which was sealed and purged once with hydrogen. The
reaction was stirred at room temperature under 80−90 bar of hydro-
gen pressure for 18 h. The solvent was removed under reduced pressure
and the products were purified by flash column chromatography (Et2O/
hexane 1:2−1:1). For screening purposes, 0.1 mmol of substrate and
2 mol % of Ir catalyst were dissolved in CH2Cl2 (0.5 mL) and submitted
to the reaction conditions above. The diastereomeric excesses were
determined by chiral HPLC (OD-H column).
3.11−2.91 (m, 2H), 2.69 (dd, 1H, J = 13.4, 9.7 Hz), 2.29−2.18 (m,
2H), 1.89−1.75 (m, 2H), 1.73 (d, 3H, J = 1.5 Hz), 1.67−1.54 (m,
1H), 0.97 (d, 3H, J = 6.5 Hz); 13C NMR (100 MHz, CDCl3) δ 173.5,
163.8, 153.6, 135.4, 133.4, 131.2, 129.9, 129.8, 129.5, 129.1, 128.7,
127.5, 121.4, 66.3, 55.3, 38.0, 37.4, 33.5, 31.3, 30.7, 19.4, 18.1.
Conjugate Reduction to 14.28 To a solution of carbamate 2b
(5.46 g, 12.7 mmol, 1.0 equiv) in degassed toluene (10 mL) were
added at rt tBuOH (1.80 mL, 19.0 mmol, 1.5 equiv) and PMHS/
CuH(BDP) solution (14.6 mL) prepared according to the procedure
of Lipshutz and co-workers. The reaction was stirred for 18 h and
diluted with saturated aq NH4Cl and Et2O. The organic phase was
dried over Na2SO4 and the solvent removed under reduced pressure.
The crude product was purified by flash column chromatography
(EtOAc/hexane 1:9 to 1:7) to give 14 (5.28 g, 12.2 mmol, 95%) as a
white solid: Rf (EtOAc/hexane 1:5) = 0.28; [α]24 = +29.4 (c 1.02,
D
CHCl3); MS (ESI) (M + Na)+ m/z 453; IR (film) 3384, 2966, 2931,
1781, 1737, 1132 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.39−7.21 (m,
3H), 7.22−7.15 (m, 2H), 6.79 (s, 1H), 5.23−5.07 (m, 1H), 4.66 (mc,
1H), 4.24−4.07 (m, 2H), 3.26 (dd, 1H, J = 13.4, 3.1 Hz), 3.09−2.98
(m, 1H), 2.98−2.84 (m, 1H), 2.76 (dd, 1H, J = 13.4, 9.5 Hz), 2.16
(dd, 1H, J = 13.1, 6.9 Hz), 1.97−1.83 (m, 1H), 1.83−1.64 (m, 2H),
1.59 (d, 3H, J = 1.1 Hz), 1.58−1.49 (m, 1H), 1.32 (s, 9H), 0.91 (d,
3H, J = 6.5 Hz); 13C NMR (100 MHz, CDCl3) δ 173.7, 153.6, 152.5,
135.29, 131.3, 129.5, 129.0, 127.4, 117.4, 66.2, 55.2, 50.5, 37.9, 36.1,
32.7, 30.4, 30.1, 28.8, 27.0, 19.7, 18.0.
Hydrogenation Product 4a. Compound 2b (180 mg, 0.418 mmol)
and [Ir(cod)6]BArF (14 mg, 0.0084 mmol, 0.02 equiv) were dissolved
in CH2Cl2 (2 mL) and submitted to the reaction conditions above
to give 4a (172 mg, 0.397 mmol, 95%, 97:3 anti/syn) as a viscous,
colorless oil after purification: Rf (EtOAc/hexane 1:5) = 0.25; HPLC
(hexane/i-PrOH 92:8) tR = 20.9 min; [α]24D = +26.0 (c 1.00, CHCl3);
HRMS found (ESI) (M + Na)+ 455.25172, C24H36N2O5Na requires
455.25164; IR (film) ν 3381, 2965, 2930, 1783, 1703, 1268, 1212,
General Procedure for the α-Methylation of Hydrogenation
Products. The hydrogenation products were dissolved in anhydrous
THF (c = 0.2 M) and cooled to −78 °C, and a solution of 2 M
NaHMDS in THF (1.15 equiv) was added dropwise. The reaction was
stirred for 45 min, and MeI (1.50 equiv) was added at −78 °C. After
TLC analysis indicated full conversion of starting material (3−4 h)
the reaction was quenched with a few drops of saturated aq NH4Cl.
The solvent was removed under reduced pressure and the crude mix-
ture was directly subjected to a silica gel column with a plug of anhydrous
Na2SO4 using toluene. Flash column chromatography (Et2O/hexane 1:3
1
1090 cm−1; H NMR (300 MHz, CDCl3) δ 7.36−7.23 (m, 3H), 7.19
(dd, 2H, J = 5.1, 3.0 Hz), 4.78−4.58 (m, 2H), 4.23−4.11 (m, 2H),
3.91−3.71 (m, 2H), 3.27 (dd, 1H, J = 13.4, 3.2 Hz), 3.94 (mc, 2H),
2.75 (dd, 1H, J = 13.4, 9.6 Hz), 1.94−1.76 (m, 1H), 1.76−1.46 (m,
3H), 1.30 (s, 9H), 1.25−1.07 (m, 2H), 0.93−0.86 (m, 6H); 13C NMR
(75 MHz, CDCl3) δ 173.6, 153.5, 135.4, 129.5, 129.0, 127.4, 69.6,
66.2, 55.2, 50.3, 40.8, 38.0, 33.4, 32.0, 30.4, 29.7, 29.1, 19.3, 16.8.
Hydrogenation Product 4b. Compound 2b (180 mg, 0.418 mmol)
and [Ir(cod)ent-6]BArF (14 mg, 0.0084 mmol, 0.02 equiv) were
dissolved in CH2Cl2 (2 mL) and submitted to the reaction conditions
above to give 4b (173 mg, 0.400 mmol, 96%, 97:3 syn/anti) as a vis-
cous, colorless oil after purification: Rf (EtOAc/hexane 1:5) = 0.25;
1
to 1:1) gave the methylated products. By H NMR analysis (400 MHz)
only a single diastereomer could be detected.
Trideoxypropionate 8. Compound 4b (2.02 g, 4.62 mmol, 1.0
equiv) was dissolved in THF (23 mL) and treated with NaHMDS
(2.65 mL, 2 M in THF, 5.31 mmol, 1.15 equiv) and MeI (0.43 mL,
6.9 mmol, 1.50 equiv) according to the general procedure above.
Purification of the crude product gave 8 (1.48 g, 3.30 mmol, 72%)
as a colorless, viscous oil: Rf (EtOAc/hexane 1:5) = 0.35; [α]24
=
D
+43.0 (c 1.00, CHCl3); HRMS found (ESI) (M + Na)+ 469.26736,
C25H38N2O5Na requires 469.26729; IR (film) ν 3384, 2965, 2931,
1780, 1701, 1092 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.36−7.26 (m,
3H), 7.24−7.21 (m, 2H), 4.79 (brs, 1H), 4.71−4.66 (m, 1H), 4.23−
4.15 (m, 2H), 3.91−3.83 (m, 2H), 3.77−3.74 (m, 1H), 3.25 (dd, 1H,
J = 13.3, 3.2 Hz), 2.77 (dd, 1H, J = 13.3, 9.6 Hz), 1.88−1.82 (m, 2H),
1.53−1.48 (m, 1H), 1.39−1.20 (m, 1H), 1.31 (s, 9H), 1.21 (d, 3H, J =
6.8 Hz), 1.15−1.08 (m, 1H), 0.98− 0.85 (m, 1H), 0.92 (d, 3H, J = 6.4
Hz), 0.87 (d, 3H, J = 6.4 Hz); 13C NMR (100 MHz, CDCl3) δ 177.4,
153.2, 135.4, 129.6, 129.0, 127.4, 68.8, 66.1, 55.3, 50.3, 41.2, 40.7, 37.9,
35.3, 30.4, 29.1, 28.2, 27.0, 20.7, 18.7, 17.9.
HPLC (hexane/i-PrOH 92:8) tR = 18.3 min; [α]24 = +36.0 (c 1.00,
D
CHCl3); HRMS found (ESI) (M + Na)+ 455.25156, C24H36N2O5Na
requires 455.25164; IR (film) ν 3391, 2964, 2930, 1784, 1704, 1267,
1211 cm−1; 1H NMR (300 MHz, CDCl3) δ 7.37−7.23 (m, 3H), 7.23−
7.16 (m, 2H), 4.75 (s, 1H), 4.66 (mc, 1H), 4.23−4.12 (m, 2H), 3.95−
3.70 (m, 2H), 3.29 (dd, 1H, J = 13.4, 3.2 Hz), 2.94 (mc, 2H), 2.76 (dd,
1H, J = 13.3, 9.6 Hz), 1.94−1.79 (m, 1H), 1.79−1.56 (m, 2H), 1.55−
1.34 (m, 2H), 1.31 (s, 9H), 1.11−0.96 (m, 1H), 0.94 (d, 3H, J = 6.4
Hz), 0.92 (d, 3H, J = 6.7 Hz); 13C NMR (75 MHz, CDCl3) δ 173.7,
153.6, 135.4, 129.5, 129.1, 127.5, 69.0, 66.3, 55.3, 50.3, 40.9, 38.0, 33.0,
30.8, 30.5, 29.7, 29.1, 20.2, 17.7.
Conjugate Reduction to 12.28 To a solution of benzoate 2a (677
mg, 1.56 mmol, 1.0 equiv) in degassed toluene (1 mL) were added at
rt tBuOH (150 μL, 3.12 mmol, 2.0 equiv) and PMHS/CuH(BDP)
solution (1.95 mL) prepared according to the procedure of Lipshutz
and co-workers. The reaction was stirred for 19 h and diluted with
saturated aq NH4Cl and Et2O. The organic phase was dried over
Na2SO4, and the solvent removed under reduced pressure. The crude
product was purified by flash column chromatography (EtOAc/hexane
1:9 to 1:7) to give 12 (612 mg, 1.41 mmol, 90%) as a colorless, viscous
Synthesis of 13. According to the general procedure for the α-
methylation, benzoate 12 (190 mg, 0.44 mmol, 1.0 equiv) was dis-
solved in THF (3 mL) and treated with NaHMDS (0.46 mL, 1 M in
THF, 0.46 mmol, 1.05 equiv) and MeI (87 μL, 1.32 mmol, 3.0 equiv).
Purification of the crude product gave 13 (164 mg, 0.37 mmol, 84%)
as a colorless, viscous oil: Rf (EtOAc/hexane 1:5) = 0.39; [α]24
=
D
+48.5 (c 1.03, CHCl3); HRMS found (ESI) (M + Na)+ 472.20934,
C27H31NO5Na requires 472.20999; IR (film) ν 2963, 2932, 1779,
1727, 1698, 1268, 1129 cm−1; H NMR (400 MHz, CDCl3) δ 8.13−
1
24
8.06 (m, 2H), 7.63−7.54 (m, 1H), 7.52−7.43 (m, 2H), 7.37−7.24 (m,
3H), 7.23−7.15 (m, 2H), 4.65 (mc, 1H), 4.23−4.10 (m, 2H), 3.93 (mc,
1H), 3.24 (dd, 1H, J = 13.4, 3.2 Hz), 2.77 (dd, 1H, J = 13.3, 9.5 Hz),
2.25 (dd, 1H, J = 13.2, 6.1 Hz), 2.14 (dd, 1H, J = 13.2, 8.7 Hz), 1.96
(mc, 1H), 1.72 (d, 3H, J = 1.3 Hz), 1.24 (d, 3H, J = 6.8 Hz), 0.91 (d,
3H, J = 6.6 Hz); 13C NMR (100 MHz, CDCl3) δ 177.2, 163.7, 153.1,
oil: Rf (EtOAc/hexane 1:5) = 0.30; [α]D = +17.7 (c 1.02, CHCl3);
HRMS found (ESI) (M + Na)+, 458.19341, C26H29NO5Na requires
458.19379; IR (film) ν 2959, 2931, 1785, 1730, 1702, 1267, 1127
1
cm−1; H NMR (400 MHz, CDCl3) δ 8.12−8.05 (m, 2H), 7.63−7.55
(m, 1H), 7.52−7.42 (m, 2H), 7.36−7.23 (m, 3H), 7.23−7.14 (m, 2H),
4.65 (mc, 1H), 4.23−4.10 (m, 2H), 3.27 (dd, 1H, J = 13.4, 3.3 Hz),
1484
dx.doi.org/10.1021/jo202330b | J. Org. Chem. 2012, 77, 1477−1488